Literature DB >> 11395590

Association of pulmonary artery catheter use with in-hospital mortality.

B Afessa1, S Spencer, W Khan, M LaGatta, L Bridges, A X Freire.   

Abstract

OBJECTIVE: To determine the association of pulmonary artery catheter (PAC) use with in-hospital mortality.
DESIGN: Prospective, observational study.
SETTING: The medical intensive care units (MICU) of two teaching hospitals.
METHODS: The study included 751 adults who were admitted to the MICU, excluding those who stayed for <24 hrs. Demographics and the worst Acute Physiology and Chronic Health Evaluation (APACHE) II score within the first 24 hrs of MICU admission were obtained. Daily logistic organ dysfunction system (LODS) scores were calculated. The associations of in-hospital mortality with the admission source, admission disease category, APACHE II scores, the worst LODS scores, mechanical ventilation, and PAC use were determined using chi-square, Mann-Whitney U, and multiple logistic regression analysis tests. p Values < 0.05 were considered significant.
RESULTS: Mean patient age was 52.6 +/- 17.1 yrs; 425 (57%) were male; 464 (62%) were African-American, 275 (37%) Caucasian, 6 (1%) Asian, and 6 (1%) Hispanic. PAC was used in 119/751 (16%). The median APACHE II and worst LODS scores were 19 and 4, respectively. The in-hospital mortality rate was 159/751 (21%). The median APACHE II score for survivors was 17.5, compared with 28.0 for nonsurvivors (p <.0001). The worst median LODS score was 4 for survivors, compared with 11 for nonsurvivors (p <.0001). Sixty-four (54%) of the 119 patients with PAC died, compared with 95 (15%) of the 632 without PAC (p <.0001). Multiple logistic regression analysis showed that higher APACHE II-predicted mortality rate (p =.0088) and worst daily LODS score (p <.0001) were associated with increased mortality. The admission source, admission disease category, PAC use, and mechanical ventilation were not associated with in-hospital mortality.
CONCLUSIONS: This study could not detect an association between PAC use and mortality. The APACHE II-predicted mortality rate and the development of multiple organ dysfunction were the main determinants of poor outcome in critically ill patients admitted to MICU.

Entities:  

Mesh:

Year:  2001        PMID: 11395590     DOI: 10.1097/00003246-200106000-00010

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Noninvasive cardiac output measurement by transthoracic electrical bioimpedence: influence of age and gender.

Authors:  Talakad N Sathyaprabha; Cauchy Pradhan; G Rashmi; Kandavel Thennarasu; Trichur R Raju
Journal:  J Clin Monit Comput       Date:  2008-11-13       Impact factor: 2.502

2.  Early non-invasive cardiac output monitoring in hemodynamically unstable intensive care patients: a multi-center randomized controlled trial.

Authors:  Jukka Takala; Esko Ruokonen; Jyrki J Tenhunen; Ilkka Parviainen; Stephan M Jakob
Journal:  Crit Care       Date:  2011-06-15       Impact factor: 9.097

3.  The pulmonary artery catheter: the tool versus treatments based on the tool.

Authors:  Jukka Takala
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

4.  Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study.

Authors:  James L Januzzi; Alexander Morss; Roderick Tung; Richard Pino; Michael A Fifer; B Taylor Thompson; Elizabeth Lee-Lewandrowski
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

Review 5.  Equipment review: the success of early goal-directed therapy for septic shock prompts evaluation of current approaches for monitoring the adequacy of resuscitation.

Authors:  Scott R Gunn; Mitchell P Fink; Benjamin Wallace
Journal:  Crit Care       Date:  2005-05-27       Impact factor: 9.097

6.  Accuracy, Precision, and Trending Ability of Electrical Cardiometry Cardiac Index versus Continuous Pulmonary Artery Thermodilution Method: A Prospective, Observational Study.

Authors:  P B W Cox; A M den Ouden; M Theunissen; L J Montenij; A G H Kessels; M D Lancé; W F F A Buhre; M A E Marcus
Journal:  Biomed Res Int       Date:  2017-10-09       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.